|

Liposomal paclitaxel Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Shanghai Pulmonary Hospital, Shanghai, China1
  • Beijing Tongren Hospital1

Indications

  • Cancer2
  • Pembrolizumab1
  • Locally Advanced1
  • Head and Neck Squamous Cell Carcinoma1
  • Lung Cancer1

Other2 trials

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Phase 3
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.